Novitas Capital
Novitas Capital is a venture capital firm based in Wayne, Pennsylvania, with additional offices in Pittsburgh, Pennsylvania, Allendale, New Jersey, and Morgantown, West Virginia. Founded in 1997, the firm specializes in seed, start-up, and early-stage investments primarily in technology and life science sectors. Novitas Capital focuses on identifying and nurturing innovative companies that demonstrate strong intellectual capital, proven leadership, and unique market positioning. With a commitment to supporting the growth and value creation of its portfolio, Novitas typically leads investment rounds and plays an active role in the success of its approximately 30 active portfolio companies. Over more than a decade of operation, Novitas has developed a robust investment philosophy and strong partner relationships, successfully generating returns in a landscape where funding for early-stage ventures is often limited. The firm currently manages around $237 million across three venture funds.
Nistica, Inc. specializes in the development and manufacturing of optical networking modules designed to enhance the delivery of high-bandwidth applications. The company offers a range of products, including reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, wave blocker arrays with optical programmability, and high port-count series products. Its FLEXBOX, a disaggregated ROADM node, is tailored for software-defined networks, while the company's ROADM linecards support various optical networking needs. Founded in 2005 and based in Bridgewater, New Jersey, Nistica serves optical system original equipment manufacturers (OEMs) both domestically and internationally, aiming to automate and simplify the optical network infrastructure. In 2012, Nistica was acquired by Molex Optical Solutions Group.
Agile Therapeutics
Series B in 2010
Agile Therapeutics is a women's healthcare company dedicated to addressing the unmet health needs of women through the development and commercialization of prescription contraceptive products. The company's lead product, Twirla, is a once-weekly transdermal patch that delivers a combination of levonorgestrel and ethinylestradiol, providing a non-daily contraceptive option. In addition to Twirla, Agile Therapeutics is advancing a pipeline of related products, including various regimens designed to offer customizable menstrual cycle management options, such as AG200-ER for extended cycles and AG200-SP for lighter periods. The firm's proprietary Skinfusion technology facilitates effective drug delivery through the skin. Headquartered in Princeton, New Jersey, Agile Therapeutics aims to enhance women's reproductive health by providing innovative contraceptive solutions.
Nistica, Inc. specializes in the development and manufacturing of optical networking modules designed to enhance the delivery of high-bandwidth applications. The company offers a range of products, including reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, wave blocker arrays with optical programmability, and high port-count series products. Its FLEXBOX, a disaggregated ROADM node, is tailored for software-defined networks, while the company's ROADM linecards support various optical networking needs. Founded in 2005 and based in Bridgewater, New Jersey, Nistica serves optical system original equipment manufacturers (OEMs) both domestically and internationally, aiming to automate and simplify the optical network infrastructure. In 2012, Nistica was acquired by Molex Optical Solutions Group.
Nistica, Inc. specializes in the development and manufacturing of optical networking modules designed to enhance the delivery of high-bandwidth applications. The company offers a range of products, including reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, wave blocker arrays with optical programmability, and high port-count series products. Its FLEXBOX, a disaggregated ROADM node, is tailored for software-defined networks, while the company's ROADM linecards support various optical networking needs. Founded in 2005 and based in Bridgewater, New Jersey, Nistica serves optical system original equipment manufacturers (OEMs) both domestically and internationally, aiming to automate and simplify the optical network infrastructure. In 2012, Nistica was acquired by Molex Optical Solutions Group.
MedCases focuses on the development of medical e-learning solutions for the pharmaceutical and biotechnology industry. MedCases offers ADHD Point of Care CME Program that focuses on educating physicians on the diagnosis and treatment of attention-deficit hyperactivity disorder. MedCases was acquired by Indegene Lifesystems in November 2006. MedCases was founded in 1971 and is based in Princeton, New Jersey.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.